Capital Access Window - Ondine Biomedical Inc.

Summary by AI BETAClose X

Ondine Biomedical Inc. has requested a temporary suspension of trading for its common shares on AIM, effective from 7:30 am on September 30, 2026, pending an announcement. This suspension is part of a Capital Access Window, indicating the company is likely preparing to disclose significant financial or strategic news that could impact its share price.

Disclaimer*

UK 100

Latest directors dealings